FDA Approves Zanvastro for Alexander Disease
FDA approved Ionis’s Zanvastro (zilganersen) for pediatric and adult Alexander disease, creating the first approved therapy for this ultra-rare GFAP-driven disorder. The quarterly intrathecal antisense oligonucleotide improved or stabilized motor outcomes in a small…
